Real‐world safety and efficacy of apixaban versus standard thromboprophylaxis in newly diagnosed multiple myeloma: Insights from a multicentre retrospective cohort study
- DOI
- 10.1111/bjh.70731
- Published
- 2026-08-12
- Container
- British Journal of Haematology
- Publisher
- Wiley
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1111/bjh.70731,
title = {Real‐world safety and efficacy of apixaban versus standard thromboprophylaxis in newly diagnosed multiple myeloma: Insights from a multicentre retrospective cohort study},
author = {Guillaume Escure and Corinne Frere and Naella Lamamra and Benjamin Crichi and Laurent Frenzel and Salomon Manier and Emilie Chalayer},
year = {2026},
journal = {British Journal of Haematology},
doi = {10.1111/bjh.70731},
url = {https://doi.org/10.1111/bjh.70731}
}RIS
TY - JOUR TI - Real‐world safety and efficacy of apixaban versus standard thromboprophylaxis in newly diagnosed multiple myeloma: Insights from a multicentre retrospective cohort study AU - Guillaume Escure AU - Corinne Frere AU - Naella Lamamra AU - Benjamin Crichi AU - Laurent Frenzel AU - Salomon Manier AU - Emilie Chalayer PY - 2026 JO - British Journal of Haematology DO - 10.1111/bjh.70731 UR - https://doi.org/10.1111/bjh.70731 ER -
APA
Escure, G., Frere, C., Lamamra, N., Crichi, B., Frenzel, L., Manier, S., & Chalayer, E. (2026). Real‐world safety and efficacy of apixaban versus standard thromboprophylaxis in newly diagnosed multiple myeloma: Insights from a multicentre retrospective cohort study. British Journal of Haematology. https://doi.org/10.1111/bjh.70731
Source records
- crossref · retrieved 2026-09-25T12:08:21.751Z